logo

Last Update

This profile was last updated on 4/10/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Geoffrey Kim?

Geoffrey Kim

Director, Division of Oncology Products 1

Food and Drug Administration

HQ Phone:  (301) 827-6500

Direct Phone: (301) ***-****direct phone

Email: g***@***.gov

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Food and Drug Administration

5600 Fishers Lane

Rockville, Maryland,20852

United States

Company Description

China's Food and Drug Administration (SFDA) is now offering a reward of about 50,000 US dollars for relevant information on counterfeit drug production. The bounty aims to "encourage the public to report illegal activities so as to determine, control and elimi...more

Background Information

Employment History

Oncologist

Hematology Oncology Safety Net Providers


Director, Division of Oncology Products In the Office

Haematology Oncology Products


Web References(6 Total References)


Thursday Presentations

www.ascpt.org [cached]

Geoffrey Kim, MD
US Food and Drug Administration, Silver Spring, MD


AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts

www.medimmune.com [cached]

Dr. Jean-Charles Soria joins MedImmune as Senior Vice President, Head of Oncology Innovative Medicines, and Dr. Geoffrey Kim has been appointed as Head of Oncology Strategic Combinations at AstraZeneca.
Dr. Bahija Jallal, Executive Vice President, MedImmune, said: "AstraZeneca and MedImmune are delighted to welcome Dr. Soria and Dr. Kim. Dr. Geoffrey Kim Dr. Geoffrey Kim and his team will focus on the development of the company's late-stage immuno-oncology combinations programme with the ultimate goal of developing combination regimens that will deliver innovative medicines to patients. Dr. Kim was most recently with the US Food and Drug Administration (FDA) where he had an impressive tenure serving as the Director, Division of Oncology Products in the Office of Haematology Oncology Products since 2015. In this role, he was tasked with the evaluation and regulation of oncology drug products that were in development and approved for breast, genitourinary, and gynecologic cancers. He was also involved with numerous cross-functional working groups, developing policies pertaining to in-vitro companion diagnostics, combination products, and therapy dose optimisation strategies for cancer medicines. Dr. Kim began working at the FDA in 2010 as a Medical Officer in the Division of Oncology Products. He received his bachelor's degree at UCLA, his medical degree at the New York Medical College, and completed his residency in internal medicine at the Montefiore Medical Center. He performed laboratory research at these institutions with a particular focus on cell adhesion molecules and cellular signaling. Dr. Kim completed his medical oncology fellowship at the National Cancer Institute (NCI) where he was active in both laboratory and clinical research in molecular signalling and ovarian cancer. Dr. Kim started at the company 17 July 2017. Both Dr. Soria and Dr. Kim will be based in Gaithersburg, Md., one of AstraZeneca's three global strategic R&D centres and MedImmune headquarters.


www.ascpt.org

Geoffrey Kim, MD
US Food and Drug Administration, Silver Spring, MD 528 N Washington St, Alexandria, VA 22314 | Ph: 703.836.6981 | info@ascpt.org


Bioinnovation…Everywhere In Translational Science

www.ascpt.org [cached]

Finally, Geoff Kim (FDA) presented a fascinating analogy about how the phonetic Korean alphabet democratized the dissemination of knowledge--and its parallels to the Information Exchange and Data Transformation (INFORMED) project at the FDA as a way to integrate data from multiple sources into a common and easily managed language.


About Us | MedImmune

www.medimmune.com [cached]

We're pleased to announce the appointment of Dr. Jean-Charles Soria & Dr. Geoffrey Kim.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory